JWH-015 (a synthetic CB2 & GPR-55 agonist) & Cannabis studies completed
Science and Research
2011 - Study ~ Beyond THC: The New Generation of Cannabinoid Designer Drugs.
2007 - Study ~ Spinal cannabinoid receptor type 2 activation reduces hypersensitivity and spinal cord glial activation after paw incision.
2006 - Study ~ CB2 cannabinoid receptor agonist, JWH-015 triggers apoptosis in immune cells: Potential role for CB2 selective ligands as immunosuppressive agents
2005 - Study ~ Avoidance
of Abeta[(25-35)] / (H(2)O(2)) -induced apoptosis in lymphocytes by the
cannabinoid agonists CP55,940 and JWH-015 via receptor-independent and
PI3K-dependent mechanisms: role of NF-kappaB and p53.
2002 - Study ~ Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease